fbpx
EVENTS|NEWS|CONTACT|DONATE
Read Our Newsletter

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
Manish Shah
Mar 12 2020

Manish Shah, MD, discusses avelumab’s effectiveness based on results from the JAVELIN 100 study

Manish Shah of Weill Cornell Medicine explains the results of a recent study in which gastric cancer patients given either chemo or the checkpoint inhibitor Bavencio (avelumab) as maintenance treatment did equally well.

Read Source
, ,

Social Media

   

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X